Glenmark Pharmaceuticals PAT History — Quarter by Quarter
Glenmark Pharmaceuticals's pat moved from ₹173 Cr in Q1 FY24 to ₹403 Cr in Q3 FY26, a 132.9% change over 11 quarters. The table keeps each quarter linked back to the underlying earnings page.
Glenmark Pharmaceuticals's pat moved from ₹173 Cr in Q1 FY24 to ₹403 Cr in Q3 FY26, a 132.9% change over 11 quarters. The table keeps each quarter linked back to the underlying earnings page.